trial · primary record
Intracerebroventricular injection of MT027 UCAR-T Cell targeting B7H3
Brain Metastases From Solid Tumors
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 40 |
| Primary completion | 2030-12-20 |
| Primary endpoint | Incidence rate of Dose-limiting toxicity (DLT) |
| Registry ID | NCT07897799 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:52.984Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07897799
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.